tiprankstipranks
Advertisement
Advertisement

INKT Stock Latest News

MiNK Therapeutics Advances Phase 2 Trial of agenT-797 in Severe Pneumonia: What Investors Should Watch
Company AnnouncementsMiNK Therapeutics Advances Phase 2 Trial of agenT-797 in Severe Pneumonia: What Investors Should Watch
5d ago
INKT
MiNK Therapeutics Stockholders Back Directors, Ratify Auditor
PremiumCompany Announcements
MiNK Therapeutics Stockholders Back Directors, Ratify Auditor
8d ago
8K
INKT
MiNK Therapeutics doses first patient in agenT-797 trial
PremiumThe Fly
MiNK Therapeutics doses first patient in agenT-797 trial
1M ago
INKT
MiNK Therapeutics reports new data on agenT-797 at ATS 2026
PremiumThe Fly
MiNK Therapeutics reports new data on agenT-797 at ATS 2026
1M ago
INKT
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
PremiumCompany Announcements
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
2M ago
INKT
MiNK Therapeutics initiates agenT-797 clinical trial
PremiumThe FlyMiNK Therapeutics initiates agenT-797 clinical trial
2M ago
INKT
Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
Premium
Ratings
Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
2M ago
INKT
MiNK Therapeutics management to meet virtually with B. Riley
Premium
The Fly
MiNK Therapeutics management to meet virtually with B. Riley
2M ago
INKT
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
PremiumRatings
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
3M ago
INKT
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
PremiumCompany Announcements
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
3M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INKT Upcoming Earnings Report: What to Expect?
3M ago
INKT
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
PremiumCompany Announcements
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
3M ago
8K
INKT
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
PremiumCompany AnnouncementsMiNK Therapeutics Appoints New Principal Financial and Accounting Officers
3M ago
8K
INKT
3 Penny Stocks to Watch Now, 3/11/26
Premium
Market News
3 Penny Stocks to Watch Now, 3/11/26
4M ago
ATPC
INKT
Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!
4M ago
GD
AMD
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
PremiumRatings
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
4M ago
INKT
Why Is MiNK Therapeutics Stock (INKT) Up Today?
PremiumMarket News
Why Is MiNK Therapeutics Stock (INKT) Up Today?
4M ago
INKT
MiNK Therapeutics announces strategic collaboration with C-Further
PremiumThe Fly
MiNK Therapeutics announces strategic collaboration with C-Further
4M ago
INKT
MiNK Therapeutics announces new invariant natural killer T cells data
PremiumThe Fly
MiNK Therapeutics announces new invariant natural killer T cells data
5M ago
INKT
MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
PremiumThe FlyMiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
6M ago
INKT
MiNK Therapeutics announces board resignation amid public appointment
Premium
Company Announcements
MiNK Therapeutics announces board resignation amid public appointment
6M ago
8K
INKT
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
Premium
The Fly
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
7M ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >